Browsing Tag
Galecto
2 posts
Galecto pivots to oncology with Damora Therapeutics buyout and massive $285m funding boost
Discover how Galecto’s $285 M Damora Therapeutics acquisition and new mutCALR antibody pipeline could transform myelofibrosis and thrombocythemia treatment.
November 10, 2025
Galecto raises $64m to develop fibrosis and cancer treatments
Galecto, a Danish biotech company, has raised $64 million in an equity financing round, for developing novel treatments…
September 26, 2020